Panelists discuss how integrating both intravenous (IV) and subcutaneous (SubQ) therapies in oncology centers requires adaptable staffing, data-driven workflow planning, and thoughtful pilot ...

Study finds abdominal fat causes more blood vessel harm than subcutaneous fat by German Centre for Cardiovascular Research (DZHK) edited by Sadie Harley, reviewed by Andrew Zinin Editors' notes ...

The phase 3 IRAKLIA trial found that subcutaneous isatuximab delivered via an on-body system was as effective and safe as intravenous (IV) administration in relapsed/refractory multiple myeloma ...

Isatuximab Subcutaneous by On-Body Injector Versus Isatuximab Intravenous Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma: Phase III IRAKLIA Study ...

The funds will support regulatory activities and the planned 510 (k) submission for approval to the U.S. Food and Drug Administration (FDA) for Flexi-Port ™ SLF-TANL ™, a novel subcutaneous port ...